Logo image of IS7.DE

INTICA SYSTEMS SE (IS7.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:IS7 - DE0005874846 - Common Stock

1.655 EUR
+0.05 (+3.12%)
Last: 11/24/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to IS7. IS7 was compared to 52 industry peers in the Electronic Equipment, Instruments & Components industry. IS7 may be in some trouble as it scores bad on both profitability and health. IS7 does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

IS7 had negative earnings in the past year.
IS7 had a positive operating cash flow in the past year.
In multiple years IS7 reported negative net income over the last 5 years.
IS7 had a positive operating cash flow in each of the past 5 years.
IS7.DE Yearly Net Income VS EBIT VS OCF VS FCFIS7.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

IS7 has a Return On Assets of -7.00%. This is in the lower half of the industry: IS7 underperforms 71.15% of its industry peers.
IS7's Return On Equity of -24.64% is on the low side compared to the rest of the industry. IS7 is outperformed by 69.23% of its industry peers.
Industry RankSector Rank
ROA -7%
ROE -24.64%
ROIC N/A
ROA(3y)-1.02%
ROA(5y)0.02%
ROE(3y)-3.67%
ROE(5y)-0.35%
ROIC(3y)N/A
ROIC(5y)N/A
IS7.DE Yearly ROA, ROE, ROICIS7.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

In the last couple of years the Operating Margin of IS7 has declined.
The Gross Margin of IS7 (43.37%) is comparable to the rest of the industry.
IS7's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for IS7 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.37%
OM growth 3Y-45.56%
OM growth 5Y-27.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.66%
GM growth 5Y1.46%
IS7.DE Yearly Profit, Operating, Gross MarginsIS7.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

IS7 does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IS7 has about the same amount of shares outstanding.
The number of shares outstanding for IS7 remains at a similar level compared to 5 years ago.
The debt/assets ratio for IS7 is higher compared to a year ago.
IS7.DE Yearly Shares OutstandingIS7.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
IS7.DE Yearly Total Debt VS Total AssetsIS7.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

IS7 has an Altman-Z score of 0.96. This is a bad value and indicates that IS7 is not financially healthy and even has some risk of bankruptcy.
IS7 has a worse Altman-Z score (0.96) than 80.77% of its industry peers.
IS7 has a debt to FCF ratio of 3.86. This is a good value and a sign of high solvency as IS7 would need 3.86 years to pay back of all of its debts.
IS7 has a better Debt to FCF ratio (3.86) than 61.54% of its industry peers.
IS7 has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of IS7 (0.34) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.86
Altman-Z 0.96
ROIC/WACCN/A
WACC5.69%
IS7.DE Yearly LT Debt VS Equity VS FCFIS7.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

IS7 has a Current Ratio of 0.84. This is a bad value and indicates that IS7 is not financially healthy enough and could expect problems in meeting its short term obligations.
IS7 has a Current ratio of 0.84. This is amonst the worse of the industry: IS7 underperforms 88.46% of its industry peers.
IS7 has a Quick Ratio of 0.84. This is a bad value and indicates that IS7 is not financially healthy enough and could expect problems in meeting its short term obligations.
IS7's Quick ratio of 0.42 is on the low side compared to the rest of the industry. IS7 is outperformed by 88.46% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.42
IS7.DE Yearly Current Assets VS Current LiabilitesIS7.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

3

3. Growth

3.1 Past

IS7 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -178.66%.
The Revenue for IS7 has decreased by -18.91% in the past year. This is quite bad
Measured over the past years, IS7 shows a small growth in Revenue. The Revenue has been growing by 1.44% on average per year.
EPS 1Y (TTM)-178.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)-18.91%
Revenue growth 3Y-9.65%
Revenue growth 5Y1.44%
Sales Q2Q%-10.33%

3.2 Future

IS7 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.68% yearly.
The Revenue is expected to grow by 3.82% on average over the next years.
EPS Next Y10.71%
EPS Next 2Y36.28%
EPS Next 3Y36.68%
EPS Next 5YN/A
Revenue Next Year-2.27%
Revenue Next 2Y1.76%
Revenue Next 3Y3.82%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IS7.DE Yearly Revenue VS EstimatesIS7.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
IS7.DE Yearly EPS VS EstimatesIS7.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

3

4. Valuation

4.1 Price/Earnings Ratio

IS7 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IS7. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IS7.DE Price Earnings VS Forward Price EarningsIS7.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IS7 is valued a bit cheaper than 69.23% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IS7 indicates a rather cheap valuation: IS7 is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.04
EV/EBITDA 7.07
IS7.DE Per share dataIS7.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

IS7's earnings are expected to grow with 36.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.28%
EPS Next 3Y36.68%

0

5. Dividend

5.1 Amount

IS7 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTICA SYSTEMS SE

FRA:IS7 (11/24/2025, 7:00:00 PM)

1.655

+0.05 (+3.12%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-08 2025-08-08
Earnings (Next)11-25 2025-11-25
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners60.42%
Ins Owner ChangeN/A
Market Cap7.10M
Revenue(TTM)65.62M
Net Income(TTM)-3.93M
Analysts45.71
Price Target3.67 (121.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.26%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-19.05%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF 1.04
P/OCF 0.78
P/B 0.44
P/tB 0.64
EV/EBITDA 7.07
EPS(TTM)-0.94
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)1.59
FCFY95.94%
OCF(TTM)2.11
OCFY127.62%
SpS15.3
BVpS3.72
TBVpS2.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7%
ROE -24.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.37%
FCFM 10.38%
ROA(3y)-1.02%
ROA(5y)0.02%
ROE(3y)-3.67%
ROE(5y)-0.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.7%
ROCE(5y)3.73%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-45.56%
OM growth 5Y-27.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.66%
GM growth 5Y1.46%
F-Score4
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.86
Debt/EBITDA 1.26
Cap/Depr 34.08%
Cap/Sales 3.43%
Interest Coverage N/A
Cash Conversion 211.31%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.42
Altman-Z 0.96
F-Score4
WACC5.69%
ROIC/WACCN/A
Cap/Depr(3y)103.63%
Cap/Depr(5y)82.04%
Cap/Sales(3y)7.51%
Cap/Sales(5y)5.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-178.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y10.71%
EPS Next 2Y36.28%
EPS Next 3Y36.68%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.91%
Revenue growth 3Y-9.65%
Revenue growth 5Y1.44%
Sales Q2Q%-10.33%
Revenue Next Year-2.27%
Revenue Next 2Y1.76%
Revenue Next 3Y3.82%
Revenue Next 5YN/A
EBIT growth 1Y-992.66%
EBIT growth 3Y-50.82%
EBIT growth 5Y-26.41%
EBIT Next Year1083.33%
EBIT Next 3Y150.22%
EBIT Next 5YN/A
FCF growth 1Y269.96%
FCF growth 3YN/A
FCF growth 5Y-9.62%
OCF growth 1Y43.35%
OCF growth 3Y29.25%
OCF growth 5Y-6.33%

INTICA SYSTEMS SE / IS7.DE FAQ

Can you provide the ChartMill fundamental rating for INTICA SYSTEMS SE?

ChartMill assigns a fundamental rating of 3 / 10 to IS7.DE.


What is the valuation status for IS7 stock?

ChartMill assigns a valuation rating of 3 / 10 to INTICA SYSTEMS SE (IS7.DE). This can be considered as Overvalued.


How profitable is INTICA SYSTEMS SE (IS7.DE) stock?

INTICA SYSTEMS SE (IS7.DE) has a profitability rating of 2 / 10.


What is the expected EPS growth for INTICA SYSTEMS SE (IS7.DE) stock?

The Earnings per Share (EPS) of INTICA SYSTEMS SE (IS7.DE) is expected to grow by 10.71% in the next year.